Atlas Trials

Study to Evaluate the Efficacy and Safety of Docetaxel Polymeric Micelle (PM) in Recurrent or Metastatic HNSCC

Clinical trial NCT02639858 · UNKNOWN

Trial details

NCT number
NCT02639858
Sponsor
Samyang Biopharmaceuticals Corporation
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2015-10-01
Primary completion
2020-09-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.